Vericel Corp (VCEL)

• Market cap: $2.11B
• 1 day: -4.19%
• 5 days: -10.45%
• 1 month: -13.65%
• 3 months: -22.43%
• 6 months: 6.74%
• Year to date: -22.43%
• 1 year: -19.19%
• 5 years: 402.35%
• 10 years: 1,525.48%
• Sector: Healthcare
• Industry: Biological Products, Except Diagnostic Substances

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

200% more funds holding in top 10

Funds holding in top 10: 1 [Q3] → 3 (+2) [Q4]

50% more first-time investments, than exits

New positions opened: 45 | Existing positions closed: 30

32% more capital invested

Capital invested by funds: $2.17B [Q3] → $2.86B (+$696M) [Q4]

19% more repeat investments, than reductions

Existing positions increased: 99 | Existing positions reduced: 83

4% more funds holding

Funds holding: 263 [Q3] → 273 (+10) [Q4]

1.87% more ownership

Funds ownership: 105.39% [Q3] → 107.27% (+1.87%) [Q4]

16% less call options, than puts

Call options by funds: $6.28M | Put options by funds: $7.49M

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $60 40% upside
• Avg. target: $63 48% upside
• High target: $67 57% upside

4 analyst ratings

• positive: 4 100%
• neutral: 0 0%
• negative: 0 0%

Truist Securities Richard Newitter 51% 1-year accuracy 22 / 43 met price target	43% upside $61	Buy Reiterated	3 Mar 2025
HC Wainwright & Co. Swayampakula Ramakanth 22% 1-year accuracy 45 / 203 met price target	40% upside $60	Buy Reiterated	28 Feb 2025
Canaccord Genuity Caitlin Cronin 21% 1-year accuracy 3 / 14 met price target	57% upside $67	Buy Maintained	3 Feb 2025
Stephens & Co. Mason Carrico 18% 1-year accuracy 5 / 28 met price target	52% upside $65	Overweight Reiterated	15 Jan 2025